Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:293-295
doi: 10.1161/01.RES.0000259327.56377.55
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, N.
Right arrow Articles by Meissner, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, N.
Right arrow Articles by Meissner, G.
(Circulation Research. 2007;100:293.)
© 2007 American Heart Association, Inc.


Editorials

Does Ca2+/Calmodulin-Dependent Protein Kinase {delta}c Activate or Inhibit the Cardiac Ryanodine Receptor Ion Channel?

Naohiro Yamaguchi, Gerhard Meissner

From the Departments of Biochemistry and Biophysics (N.Y., G.M.), and Cell and Molecular Physiology (G.M.), University of North Carolina, Chapel Hill, NC.

Correspondence to Gerhard Meissner, Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599-7260. E-mail meissner@med.unc.edu



See related article, pages 399–407


Key Words: Ca2+/calmodulin dependent protein kinase II • cardiac ryanodine receptor • protein phosphorylation • heart failure


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The multifunctional Ca2+/calmodulin-dependent protein kinase II{delta} (CaMKII{delta}) modulates cardiac muscle function by regulating Ca2+ transport proteins and nuclear signaling molecules. Aberrant activity of CaMKII{delta} is implicated in heart disease. In this issue, Yang et al1 report that acute overexpression of constitutively active splice variant CaMKII{delta}C phosphorylates the cardiac ryanodine receptor ion channel (RyR2) to decrease the rate of occurrence of local Ca2+ release events (Ca2+ sparks) and Ca2+ waves in cultured rat cardiomyocytes. A dominant negative form of CaMKII{delta}C was shown to have opposite effects.

The cardiac ryanodine receptors are cation selective channels that release Ca2+ from an intracellular Ca2+ storing compartment, the sarcoplasmic reticulum (SR), during a cardiac muscle action potential, in a process known as excitation-contraction coupling.2 Released Ca2+ cause cardiac muscle to contract. Sequestration of released Ca2+ by the SR Ca2+-transporting ATPase and extrusion by the Na+-Ca2+ exchanger restore the myofibrillar Ca2+ concentration from 10–6 - 10–5 to {approx}10–7 M, causing muscle to relax. The RyR2s are regulated by a variety of effectors.3 During a cardiac action potential, closely apposed dihydropyridine-sensitive L-type Ca2+ channels in the surface membrane and T-tubule mediate influx of Ca2+, which triggers massive release of Ca2+ from SR by opening RyR2s. In addition to Ca2+, endogenous effectors such as Mg2+, ATP, reactive oxygen and nitrogen molecules regulate RyR2. RyR2 is also regulated by calmodulin, cAMP-dependent protein kinase A (PKA), calmodulin-dependent kinase II (CaMKII), protein kinase C, and protein phosphatases 1 and 2A. Phosphorylation of RyR2-Ser2030 by . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Singh, M. Salih, and B. S. Tuana
{alpha}-Kinase Anchoring Protein {alpha}KAP Interacts with SERCA2A to Spatially Position Ca2+/Calmodulin-dependent Protein Kinase II and Modulate Phospholamban Phosphorylation
J. Biol. Chem., October 9, 2009; 284(41): 28212 - 28221.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
Y. Ikeda, M. Hoshijima, and K. R. Chien
Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure
Physiology, February 1, 2008; 23(1): 6 - 16.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Liu and S. G. Priori
Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin
Cardiovasc Res, January 15, 2008; 77(2): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. R. Sipido
CaM or cAMP: Linking {beta}-Adrenergic Stimulation to 'Leaky' RyRs
Circ. Res., February 16, 2007; 100(3): 296 - 298.
[Full Text] [PDF]